| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |